Michela De Meo

Sapienza, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

Interactions Between Circulating Tumor Cells and the Immune System in Colorectal Cancer: Friends or Foes?

Interactions Between Circulating Tumor Cells and the Immune System in Colorectal Cancer: Friends or Foes?

Journal: Cancers

Published: April 30, 2026

Organotropism-specific circulating tumor cells profiles: Morphology and heterotypic clustering predict metastatic sites in liquid biopsy of solid tumors.

Organotropism-specific circulating tumor cells profiles: Morphology and heterotypic clustering predict metastatic sites in liquid biopsy of solid tumors.

Journal: European journal of cancer (Oxford, England : 1990)

Published: April 29, 2026

The ACCEPTance of automation: refining circulating tumor cells enumeration for improved metastatic colorectal cancer prognosis.

The ACCEPTance of automation: refining circulating tumor cells enumeration for improved metastatic colorectal cancer prognosis.

Journal: Molecular oncology

Published: April 08, 2025

Evolution of Neo-RAS-WT in Circulating Tumor DNA from First-Line to Subsequent Therapies in Metastatic Colorectal Cancer.

Evolution of Neo-RAS-WT in Circulating Tumor DNA from First-Line to Subsequent Therapies in Metastatic Colorectal Cancer.

Journal: Cancers

Published: January 28, 2025

Blood Extracellular Vesicles Beyond Circulating Tumour Cells: A Valuable Risk Stratification Biomarker in High-Risk Non-Muscle-Invasive Bladder Cancer Patients.

Blood Extracellular Vesicles Beyond Circulating Tumour Cells: A Valuable Risk Stratification Biomarker in High-Risk Non-Muscle-Invasive Bladder Cancer Patients.

Journal: Biomedicines

Published: September 11, 2024

Circulating Cancer-Associated Macrophage-like Cells as a Blood-Based Biomarker of Response to Immune Checkpoint Inhibitors.

Circulating Cancer-Associated Macrophage-like Cells as a Blood-Based Biomarker of Response to Immune Checkpoint Inhibitors.

Journal: International journal of molecular sciences

Published: February 19, 2024

Early Detection of Disease Progression in Metastatic Cancers: Could CTCs Improve RECIST Criteria?

Early Detection of Disease Progression in Metastatic Cancers: Could CTCs Improve RECIST Criteria?

Journal: Biomedicines

Published: January 04, 2024

Prognostic Role of Circulating Tumor Cell Trajectories in Metastatic Colorectal Cancer.

Prognostic Role of Circulating Tumor Cell Trajectories in Metastatic Colorectal Cancer.

Journal: Cells

Published: March 02, 2023

Genomic landscape and survival analysis of ctDNA "neo-RAS wild-type" patients with originally RAS mutant metastatic colorectal cancer.

Genomic landscape and survival analysis of ctDNA "neo-RAS wild-type" patients with originally RAS mutant metastatic colorectal cancer.

Journal: Frontiers in oncology

Published: February 07, 2023

RAS Mutation Conversion in Bevacizumab-Treated Metastatic Colorectal Cancer Patients: A Liquid Biopsy Based Study.

RAS Mutation Conversion in Bevacizumab-Treated Metastatic Colorectal Cancer Patients: A Liquid Biopsy Based Study.

Journal: Cancers

Published: January 14, 2022

In vitro cultures of circulating tumor cells: a potential tool to unravel drug sensitivity.

In vitro cultures of circulating tumor cells: a potential tool to unravel drug sensitivity.

Journal: Cancer drug resistance (Alhambra, Calif.)

Published: November 15, 2021

Showing 1-11 of 11

Last Updated: 09/26/2026